KBC Group NV Has $174.36 Million Stake in Corteva, Inc. $CTVA

KBC Group NV raised its holdings in Corteva, Inc. (NYSE:CTVA) by 58.8% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,082,909 shares of the company’s stock after purchasing an additional 771,480 shares during the period. KBC Group NV’s holdings in Corteva were worth $174,360,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. JPL Wealth Management LLC bought a new position in shares of Corteva during the third quarter worth approximately $25,000. Westfuller Advisors LLC boosted its stake in shares of Corteva by 2,764.3% in the first quarter. Westfuller Advisors LLC now owns 401 shares of the company’s stock valued at $34,000 after buying an additional 387 shares during the period. Garton & Associates Financial Advisors LLC acquired a new stake in Corteva during the fourth quarter worth approximately $27,000. Bank of Jackson Hole Trust acquired a new position in Corteva in the 4th quarter valued at $28,000. Finally, Cornerstone Financial Management LLC acquired a new position in Corteva in the 4th quarter valued at $29,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Trading Up 0.1%

Shares of CTVA stock opened at $87.42 on Monday. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $88.22. The stock’s fifty day moving average price is $80.86 and its two-hundred day moving average price is $78.26. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. The company has a market cap of $58.47 billion, a PE ratio of 51.43, a P/E/G ratio of 2.67 and a beta of 0.56.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The company had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. During the same quarter in the previous year, the firm earned $1.13 EPS. Corteva’s revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities analysts predict that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were paid a dividend of $0.18 per share. The ex-dividend date of this dividend was Monday, June 1st. This represents a $0.72 annualized dividend and a yield of 0.8%. Corteva’s payout ratio is presently 42.35%.

Analyst Ratings Changes

Several analysts have recently issued reports on CTVA shares. Royal Bank Of Canada increased their target price on Corteva from $95.00 to $97.00 and gave the stock an “outperform” rating in a report on Thursday, May 7th. BNP Paribas Exane boosted their price target on Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. Weiss Ratings raised shares of Corteva from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, May 7th. The Goldman Sachs Group increased their price objective on shares of Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research note on Tuesday, April 14th. Finally, Zacks Research raised shares of Corteva from a “hold” rating to a “strong-buy” rating in a report on Monday, July 13th. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have given a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $88.95.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.